News | Oncology Diagnostics | October 27, 2017

Researchers Identify Major Factors Impacting Racial and Ethnic Disparities in Cancer Survival

Large study finds stage at diagnosis, neighborhood socioeconomic status and marital status have the greatest impact on racial/ethnic cancer survival disparities

Researchers Identify Major Factors Impacting Racial and Ethnic Disparities in Cancer Survival

October 27, 2017 — Racial/ethnic disparities in cancer survival in the U.S. are well documented, but the underlying causes are not well understood. To better explain disparities, researchers examined cancer survival by racial/ethnic group for 877,662 patients diagnosed with breast, prostate, colorectal or lung cancer between 2000–2013 using California Cancer Registry data.

In the study published in the Journal of Clinical Oncology, researchers found stage at diagnosis, neighborhood socioeconomic status and marital status to have the biggest impact on racial/ethnic cancer survival disparities.

Black patients had the lowest survival rate for all cancer types and Asian American/Pacific Islander ethnic groups had the highest survival, compared to Whites.

Black patients with breast, prostate and colorectal cancer were more likely to be diagnosed with late stage tumors than Whites, with stage explaining 16-28 percent of overall racial/ethnic survival disparities.

Living in a low socioeconomic neighborhood, far more common among Black and Hispanic patients than among Whites or Asian Americans/Pacific Islanders, explained 5-18 percent of the overall survival disparities among racial/ethnic groups, with the largest contribution for lung cancer.

The most significant racial/ethnic survival disparities were among women with breast cancer. Cancer deaths among Black women was twice that of White women. Hormone receptor status was a significant contributor to overall breast cancer racial/ethnic survival disparities, explaining 9 percent of survival differences. These findings reinforce that tumor subtype is a significant contributor to survival disparities, especially for the poor survival among Black compared to White women.

Researchers also found the contribution of stage at diagnosis to survival disparities in colorectal cancer was considerably larger in women (28 percent) than in men (16 percent). Among men with colorectal cancer, the influence of marital status on racial/ethnic survival disparities was as large as the influence of stage.

Women also experienced improved lung cancer survival rates over men. This may be explained by tumor biology, an important contributing factor to racial/ethnic survival disparities in lung cancer, especially in women, and may reflect the varying distribution of tumor subtypes across racial/ethnic groups.

Married patients, particularly men, also experienced improved survival over unmarried patients. Marital status explained 14-18 percent of survival disparities among men, and 6-14 percent among women.

In this study, health insurance was not found to be a significant contributor of racial/ethnic survival disparities after clinical factors, neighborhood socioeconomic status and marital status were accounted for.

According to Elizabeth Ellis, the leader researcher of the study, “While stage at diagnosis and the molecular type of tumor had the largest impact on racial/ethnic survival disparities, social factors were also important. The strong influence of neighborhood socioeconomic status and marital status suggests that social determinants, support mechanisms and access to healthcare need to be addressed to ensure that all groups have the opportunity to experience optimal survival.”

The collection of cancer incidence data used in this study was supported by the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California.

For more information: www.jco.org

Related Content

Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
Check-Cap Initiates U.S. Pilot Study of C-Scan for Colorectal Cancer Screening
News | Colonoscopy Systems | April 15, 2019
Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through...
Deep Lens Closes Series A Financing for Digital AI Pathology Platform
News | Digital Pathology | April 09, 2019
Digital pathology company Deep Lens Inc. announced the closing of a $14 million Series A financing that will further...
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...
Lunit Showcases AI Solution for Breast Cancer at SBI 2019
News | Artificial Intelligence | April 02, 2019
Medical artificial intelligence (AI) startup Lunit announced its attendance at the Society of Breast Imaging (SBI) 2019...
News | Biopsy Systems | March 29, 2019
Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy...